SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 219 filers reported holding SEATTLE GENETICS INC in Q2 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $163,713,000 | +19.6% | 836,587 | +3.9% | 0.06% | +12.2% |
| Q2 2020 | $136,835,000 | +47.6% | 805,294 | +0.3% | 0.05% | +25.6% |
| Q1 2020 | $92,681,000 | +40.9% | 803,261 | +39.5% | 0.04% | +95.0% |
| Q4 2019 | $65,782,000 | +107.4% | 575,723 | +55.0% | 0.02% | +150.0% |
| Q3 2019 | $31,712,000 | +31.1% | 371,339 | +6.2% | 0.01% | +33.3% |
| Q2 2019 | $24,197,000 | +191.5% | 349,613 | +208.4% | 0.01% | +100.0% |
| Q1 2019 | $8,302,000 | +98.9% | 113,355 | +53.9% | 0.00% | +50.0% |
| Q4 2018 | $4,174,000 | -29.5% | 73,667 | -4.1% | 0.00% | 0.0% |
| Q3 2018 | $5,924,000 | -57.8% | 76,817 | -63.7% | 0.00% | -60.0% |
| Q2 2018 | $14,049,000 | -14.8% | 211,608 | -32.9% | 0.01% | -16.7% |
| Q1 2018 | $16,497,000 | -12.7% | 315,205 | -10.8% | 0.01% | -14.3% |
| Q4 2017 | $18,904,000 | -0.5% | 353,358 | +1.2% | 0.01% | 0.0% |
| Q3 2017 | $19,007,000 | +30.7% | 349,328 | +24.3% | 0.01% | +40.0% |
| Q2 2017 | $14,546,000 | +74.2% | 281,145 | +111.7% | 0.01% | +66.7% |
| Q1 2017 | $8,349,000 | +2.0% | 132,816 | -14.4% | 0.00% | 0.0% |
| Q4 2016 | $8,189,000 | -15.5% | 155,183 | -13.5% | 0.00% | 0.0% |
| Q3 2016 | $9,688,000 | +22.1% | 179,370 | -8.7% | 0.00% | 0.0% |
| Q2 2016 | $7,937,000 | -82.2% | 196,420 | -84.5% | 0.00% | -83.3% |
| Q1 2016 | $44,545,000 | -23.5% | 1,269,441 | -2.2% | 0.02% | -21.7% |
| Q4 2015 | $58,234,000 | +13.0% | 1,297,542 | -2.9% | 0.02% | +4.5% |
| Q3 2015 | $51,553,000 | -19.9% | 1,336,959 | +0.6% | 0.02% | -12.0% |
| Q2 2015 | $64,347,000 | +31.4% | 1,329,486 | -4.0% | 0.02% | +31.6% |
| Q1 2015 | $48,958,000 | +14.9% | 1,384,942 | +4.5% | 0.02% | +18.8% |
| Q4 2014 | $42,596,000 | -6.5% | 1,325,748 | +8.2% | 0.02% | -11.1% |
| Q3 2014 | $45,560,000 | -4.3% | 1,225,395 | -1.5% | 0.02% | -5.3% |
| Q2 2014 | $47,603,000 | -1.0% | 1,244,522 | +17.9% | 0.02% | -5.0% |
| Q1 2014 | $48,085,000 | +0.6% | 1,055,416 | -11.9% | 0.02% | +5.3% |
| Q4 2013 | $47,775,000 | -3.4% | 1,197,651 | +6.2% | 0.02% | -9.5% |
| Q3 2013 | $49,444,000 | +39.1% | 1,128,071 | -0.1% | 0.02% | +23.5% |
| Q2 2013 | $35,539,000 | – | 1,129,658 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |